Showing results (211-220 of 345) with videos related to

Sort By:
Pageof 35
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 26, 2017
Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunctionYuya Matsue, Jozine M Ter Maaten, Makoto Suzuki, et al.
ESC Heart Failure|April 28, 2026
Evaluation and management of recent onset cardiomyopathy in the current era of heart failure therapeutics. A clinical consensus statement of the Heart Failure Association of the ESCHadi Skouri, Amr Abdin, Wilfried Mullens, et al.
European Journal of Preventive Cardiology|August 17, 2021
Impact of sex-specific target dose in chronic heart failure patients with reduced ejection fractionJesse F Veenis, Hans-Peter Brunner-La Rocca, Gerard C M Linssen, et al.
Journal of Cardiac Failure|September 25, 2016
Clinical Correlates and Prognostic Value of Proenkephalin in Acute and Chronic Heart FailureYuya Matsue, Jozine M Ter Maaten, Joachim Struck, et al.
European Journal of Heart Failure|December 5, 2015
Optimizing clinical use of biomarkers in high-risk acute heart failure patientsBiniyam G Demissei, Mattia A E Valente, John G Cleland, et al.
Journal of Cardiac Failure|July 19, 2019
Trajectories of Changes in Renal Function in Patients with Acute Heart FailureIris E Beldhuis, Koen W Streng, Peter van der Meer, et al.
Nature Medicine|June 26, 2026
Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trialPeter C Kahr, Fabian Aus dem Siepen, Olivier Lairez, et al.
European Heart Journal|February 12, 2025
Pregnancies in women after peri-partum cardiomyopathy: the global European Society of Cardiology EuroObservational Research Programme Peri-Partum Cardiomyopathy RegistryKaren Sliwa, Alice Jackson, Charle Viljoen, et al.
International Journal of Cardiology|June 1, 2022
Heart failure with normal LVEF in BIOSTAT-CHFLukas Baumhove, Jasper Tromp, Sylwia Figarska, et al.
International Journal of Molecular Sciences|April 30, 2021
ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca2+ Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδMario G Pavez-Giani, Pablo I Sánchez-Aguilera, Nils Bomer, et al.
Pageof 35